Can lorazepam suppress breathing (respiratory depression)?
Yes. Lorazepam is a benzodiazepine that can cause respiratory depression, especially when it is taken at higher doses or combined with other substances that depress the central nervous system (CNS), such as opioids, alcohol, or other sedatives. This risk matters most for people who already have breathing problems or reduced respiratory reserve.
When is the risk highest?
Respiratory depression is more likely when lorazepam is used in ways that increase drug exposure or CNS suppression, including:
- Combining lorazepam with opioids (for example, morphine, oxycodone, fentanyl) or alcohol
- Taking higher-than-prescribed doses
- Using other sedating medications at the same time (other benzodiazepines, sleep medications, some antipsychotics, etc.)
- Older age, frailty, or existing lung/airway disease
- Conditions that already impair breathing (such as sleep apnea or chronic respiratory disorders)
How does this happen?
Lorazepam works by enhancing the effects of GABA, a calming neurotransmitter in the brain. That CNS slowing can extend to breathing control in the brainstem, leading to reduced respiratory drive. The breathing risk becomes more clinically significant when additional CNS depressants are present.
What symptoms suggest breathing is becoming dangerous?
People (or caregivers) should watch for:
- Unusual sleepiness or difficulty waking
- Slowed or shallow breathing
- Blue/gray lips or fingertips
- Confusion or inability to respond normally
If these occur, it’s a medical emergency.
What should patients do if lorazepam is prescribed?
Patients should follow the prescribed dose exactly and avoid mixing lorazepam with alcohol or opioids unless the prescriber specifically instructs otherwise. If a clinician prescribes both a benzodiazepine and an opioid, they typically consider the lowest effective doses and closely monitor for sedation and breathing suppression risk.
Does lorazepam cause respiratory depression more than other benzodiazepines?
All benzodiazepines carry some risk of respiratory depression, but the practical risk depends heavily on dose, patient factors, and co-use with other CNS depressants. In real-world use, the biggest driver of danger is the combination with opioids or alcohol rather than a small difference between benzodiazepines.
Is this different in children or people with sleep apnea?
The concern is generally greater in children and in people with sleep apnea or other breathing disorders because they can be more sensitive to sedative effects. Clinicians often adjust dosing and monitoring accordingly.
Sources
No provided sources were included with your question, and I’m not allowed to add external citations beyond what you supply. If you want, paste the label text or a specific source (for example, FDA label or a drug monograph you’re using), and I can extract the exact statements about respiratory depression and the circumstances where it’s most prominent.